Cargando…
Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives
Although initial surgical excision cures 95% of patients, a minority of cutaneous squamous cell carcinomas (cSCCs) are judged to be unresectable, either locally advanced or with unresectable regional lymph nodes or distant metastases. These patients are offered systemic treatments. Response rate to...
Autores principales: | Alberti, Andrea, Bossi, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766667/ https://www.ncbi.nlm.nih.gov/pubmed/35070956 http://dx.doi.org/10.3389/fonc.2021.727027 |
Ejemplares similares
-
Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New Challenges
por: Lorini, Luigi, et al.
Publicado: (2023) -
Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
por: Boutros, Andrea, et al.
Publicado: (2021) -
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports
por: Colombo, Elena, et al.
Publicado: (2023) -
Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma
por: McLean, Luke S., et al.
Publicado: (2022) -
Case report: The power of immunotherapy in advanced cutaneous squamous cell carcinoma
por: Brockwell, Maximilian, et al.
Publicado: (2023)